These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 11934654)
1. Use of low potency estrogens does not reduce the risk of hip fracture. Michaëlsson K; Baron JA; Farahmand BY; Ljunghall S Bone; 2002 Apr; 30(4):613-8. PubMed ID: 11934654 [TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women. Grodstein F; Stampfer MJ; Falkeborn M; Naessen T; Persson I Epidemiology; 1999 Sep; 10(5):476-80. PubMed ID: 10468418 [TBL] [Abstract][Full Text] [Related]
3. Oral-contraceptive use and risk of hip fracture: a case-control study. Michaëlsson K; Baron JA; Farahmand BY; Persson I; Ljunghall S Lancet; 1999 May; 353(9163):1481-4. PubMed ID: 10232314 [TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. Michaëlsson K; Baron JA; Farahmand BY; Johnell O; Magnusson C; Persson PG; Persson I; Ljunghall S BMJ; 1998 Jun; 316(7148):1858-63. PubMed ID: 9632404 [TBL] [Abstract][Full Text] [Related]
5. Variation in the efficacy of hormone replacement therapy in the prevention of hip fracture. Swedish Hip Fracture Study Group. Michaëlsson K; Baron JA; Johnell O; Persson I; Ljunghall S Osteoporos Int; 1998; 8(6):540-6. PubMed ID: 10326058 [TBL] [Abstract][Full Text] [Related]
6. Influence of parity and lactation on hip fracture risk. Michaëlsson K; Baron JA; Farahmand BY; Ljunghall S Am J Epidemiol; 2001 Jun; 153(12):1166-72. PubMed ID: 11415951 [TBL] [Abstract][Full Text] [Related]
7. Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Baron JA; Farahmand BY; Weiderpass E; Michaëlsson K; Alberts A; Persson I; Ljunghall S Arch Intern Med; 2001 Apr; 161(7):983-8. PubMed ID: 11295961 [TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Weiderpass E; Persson IR J Natl Cancer Inst; 2002 Apr; 94(7):497-504. PubMed ID: 11929950 [TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study. Naessén T; Persson I; Adami HO; Bergström R; Bergkvist L Ann Intern Med; 1990 Jul; 113(2):95-103. PubMed ID: 2360759 [TBL] [Abstract][Full Text] [Related]
10. Body size and hip fracture risk. Swedish Hip Fracture Study Group. Farahmand BY; Michaëlsson K; Baron JA; Persson PG; Ljunghall S Epidemiology; 2000 Mar; 11(2):214-9. PubMed ID: 11021622 [TBL] [Abstract][Full Text] [Related]
11. Past and recent physical activity and risk of hip fracture. Jaglal SB; Kreiger N; Darlington G Am J Epidemiol; 1993 Jul; 138(2):107-18. PubMed ID: 8342529 [TBL] [Abstract][Full Text] [Related]
12. Exercise and other factors in the prevention of hip fracture: the Leisure World study. Paganini-Hill A; Chao A; Ross RK; Henderson BE Epidemiology; 1991 Jan; 2(1):16-25. PubMed ID: 2021661 [TBL] [Abstract][Full Text] [Related]
13. Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment. Yates J; Barrett-Connor E; Barlas S; Chen YT; Miller PD; Siris ES Obstet Gynecol; 2004 Mar; 103(3):440-6. PubMed ID: 14990403 [TBL] [Abstract][Full Text] [Related]
14. Diet and hip fracture risk: a case-control study. Study Group of the Multiple Risk Survey on Swedish Women for Eating Assessment. Michaëlsson K; Holmberg L; Mallmin H; Sörensen S; Wolk A; Bergström R; Ljunghall S Int J Epidemiol; 1995 Aug; 24(4):771-82. PubMed ID: 8550275 [TBL] [Abstract][Full Text] [Related]
15. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. Kiel DP; Felson DT; Anderson JJ; Wilson PW; Moskowitz MA N Engl J Med; 1987 Nov; 317(19):1169-74. PubMed ID: 3657888 [TBL] [Abstract][Full Text] [Related]
16. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S; JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697 [TBL] [Abstract][Full Text] [Related]
17. Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort. Engel P; Fabre A; Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F Am J Epidemiol; 2011 Jul; 174(1):12-21. PubMed ID: 21555715 [TBL] [Abstract][Full Text] [Related]
18. The risk of hip fracture in postmenopausal females with or without estrogen drug exposure. Johnson RE; Specht EE Am J Public Health; 1981 Feb; 71(2):138-44. PubMed ID: 7457682 [TBL] [Abstract][Full Text] [Related]
19. An epidemiologic study of hip fracture in postmenopausal women. Kreiger N; Kelsey JL; Holford TR; O'Connor T Am J Epidemiol; 1982 Jul; 116(1):141-8. PubMed ID: 7102649 [TBL] [Abstract][Full Text] [Related]
20. Physical activity and hip fracture: a population-based case-control study. Swedish Hip Fracture Study Group. Farahmand BY; Persson PG; Michaëlsson K; Baron JA; Alberts A; Moradi T; Ljunghall S Int J Epidemiol; 2000 Apr; 29(2):308-14. PubMed ID: 10817130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]